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Abstract
It was recently shown that a long non-coding RNA (lncRNA), that we named the 91H RNA (i.e. antisense H19 transcript), is
overexpressed in human breast tumours and contributes in trans to the expression of the Insulin-like Growth Factor 2 (IGF2)
gene on the paternal chromosome. Our preliminary experiments suggested that an H19 antisense transcript having a similar
function may also be conserved in the mouse. In the present work, we further characterise the mouse 91H RNA and, using a
genetic complementation approach in H19 KO myoblast cells, we show that ectopic expression of the mouse 91H RNA can
up-regulate Igf2 expression in trans despite almost complete unmethylation of the Imprinting-Control Region (ICR). We then
demonstrate that this activation occurs at the transcriptional level by activation of a previously unknown Igf2 promoter
which displays, in mouse tissues, a preferential mesodermic expression (Pm promoter). Finally, our experiments indicate that
a large excess of the H19 transcript can counteract 91H-mediated Igf2 activation. Our work contributes, in conjunction with
other recent findings, to open new horizons to our understanding of Igf2 gene regulation and functions of the 91H/H19
RNAs in normal and pathological conditions.
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Introduction
Long non-coding RNAs (lncRNAs) are major components of
the mammalian transcriptome (for a review, see ref. [1]). Recent
efforts to better characterize such transcripts revealed that they
play important roles in both oncogenic and tumour suppressive
pathways [2]. LncRNAs display a myriad of molecular functions
[3], from chromatin remodelling (ANRIL, HOTAIR, Xist) [4,5,6,7]
and modulation of alternative splicing (Zeb2/Sip1 gene locus) [8],
to RNA metabolism (1/2-sbs and HULC RNAs) [9,10] and
generation of micro- and small-RNAs (MEG3/Gtl2 and MALAT1
transcripts) [11,12]. They also have a great variety of forms: most
of them are generated by the RNA polymerase II, but some are
synthesized by the RNA Pol III (BC200 RNA) [13]; moreover,
while most are poly-adenylated, many lncRNAs remain unpoly-
adenylated [14] like, for example, the natural Sense-Antisense
transcripts (SAT) [15] which are known to overlap each other and
are co-ordinately expressed [16].
Several lncRNA are also produced from imprinted genes, whose
expression is depending on the parental origin of the chromosome.
Among them, the Airn and Kcnq1ot1 transcripts have been shown to
‘‘coat’’ the imprinted locus on the paternal chromosome from
which they are expressed. Interestingly, both transcripts are known
to interact with the histone H3 Lysine 9 methyltransferase G9a
and to repress multiple genes in cis on the paternal chromosome
[17]. Finally, two genes encoding imprinted lncRNAs map
downstream the Insulin-like Growth Factor 2 gene (Igf2) : one is the
recently described PIHit [18] and another is the H19 gene.
Since its discovery, twenty years ago [19], the function of the
H19 gene remains enigmatic. H19 gene silencing is associated with
the appearance of Wilms’ tumours in the Beckwith-Wiedemann
syndrome [20,21]. Furthermore, ectopic expression of the H19
gene in human embryonic tumour cell lines leads to loss of
clonogenicity and reduced tumourigenicity in nude mice [22]. It
was recently confirmed that, in the mouse, H19 acts as a tumour
suppressor [23]. However, several studies have also shown that the
H19 RNA can accumulate in cancer cells and tumours
[24,25,26,27,28] and it has been considered as an oncofetal
RNA by some authors [29]. The gene encodes an untranslated
RNA which is expressed only when maternally inherited.
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oppositely imprinted Insulin-like growth factor-2 (Igf2) gene, depends
on the paternal-specific DNA methylation of an Imprinting-
Control Region (ICR) located between 2 and 4 kb upstream of the
H19 gene [30]. This methylation is acquired during male
gametogenesis and prevents the binding of CTCF, an insulator
protein. On the unmethylated maternal allele, CTCF is bound to
the ICR and creates a boundary which prevents interactions
between enhancers, located downstream of the H19 gene, and the
Igf2 gene [31].
While the mechanisms of imprinting at the Igf2/H19 locus have
focused much attention, very little is known about transcriptional
regulation of the expressed Igf2 and H19 alleles. The two genes are
tightly co-regulated during mouse embryonic development and are
repressed shortly after birth in most tissues. Both genes belong to a
network of coexpressed imprinted genes (Imprinted Gene
Network, IGN) that may control embryonic growth in the mouse
[32]. Recently, the non-coding H19 RNA was shown to contribute
to the trans regulation of at least 9 genes of the IGN [33]. However,
whether the H19 transcript acts through direct or indirect
mechanisms and which step of gene expression is affected by
such a regulation have not yet been investigated. Interestingly, we
recently discovered in human that an antisense H19 transcript,
named the 91H RNA (or H19os for ‘‘H19 opposite strand’’
transcript), augments in trans the paternal IGF2 expression which is
known to favour tumour progression. In agreement with this
notion, the 91H RNA is a large nuclear transcript which
accumulates in breast tumours by RNA stabilization [34].
Preliminary experiments indicated that the antisense H19 tran-
script is evolutionarily conserved and expressed during the
perinatal period in the mouse. In this work, we present further
insights about the function of the mouse 91H and H19 transcripts.
Using a genetic inactivation/complementation approach in
cultured murine myoblasts, we show that ectopic expression of
91H RNA is sufficient to trans-activate Igf2 at the transcriptional
level, despite hypomethylation of the H19 ICR. Interestingly, this
trans-activation occurs via a novel Igf2 promoter (Igf2 Pm). Our
experiments also indicate that a large excess of H19 RNA seems to
counteract this effect. Globally, our work suggests that H19 sense
and antisense RNAs are antagonist trans riboregulators of Igf2
transcription.
Results
Characterization of the Mouse 91H RNA
Preliminary experiments showed that an H19 antisense
transcript, called the 91H RNA, that controls IGF2 gene
expression in human breast cancer cells is conserved in the mouse
[34]. The 91H RNA is a short-lived nuclear transcript which is co-
regulated with the Igf2 and H19 genes, during the perinatal period.
Our first aim was to further characterize the mouse transcript
before investigating the mechanisms by which it may exert its
function. We previously determined in mouse liver the transcrip-
tional orientation of the 91H RNA upstream of the H19
endodermic enhancers (mE region, see Figure 1 and Figure S2B
of ref. [34]). Since the human H19 antisense RNA is initiated
further downstream, in the intron 1 of the MRPL23 gene [34], we
investigated in the mouse the intergenic region located down-
stream of the H19 endodermic enhancers. In the heart, strand-
specific RT-qPCR quantifications showed that the antisense
transcript is mostly initiated downstream of the H19 enhancers
(data not shown), reminiscent to the human situation [34].
However, in the mouse liver, we found only little antisense
relative to the sense transcript downstream of the enhancers (data
not shown). Since, upstream the enhancers, we found substantial
amounts of antisense transcript [34], we can conclude that,
opposite to the situation in the heart, in liver, most of the 91H
RNA is initiated within the endodermic enhancer region. As
shown previously [34,35], within the H19 ICR and its upstream
sequences short non-coding transcripts are initiated in both sense
and antisense directions on both parental alleles, thus impairing
further characterisation of the 39 end of the 91H RNA.
59RACE experiment from the capped fraction of non-polyad-
enylated d7 mouse liver RNAs then mapped the Transcription
Start Site (TSS) of the 91H RNA more precisely within the
endodermic enhancer 2 (position chr7: 149,755,206 or chr7:
149,755,207 on mouse July 2007/ mm9 Assembly) (Figure 2).
Finally, using mice carrying a maternal deletion of the H19
transcription unit (H19
D3 mutant) [36] and a primer pair specific
of the wild-type allele (mJ PCR amplicon, that amplifies through the
59 end of the H19
D3 deletion over the H19 transcription start site,
Figure 1), we assessed by RT-qPCR that no paternal allele-specific
transcript can be detected immediately upstream of the H19 gene
(data not shown) while it can be detected further downstream on
this allele [34]. Therefore, as previously suggested [34], the mouse
91H RNA transcription stops within the H19 gene region on the
paternal allele (Figure 1).
H19 KO Myoblasts Display Low ICR Methylation and
Weak Igf2 Expression Levels
We previously showed that the mouse H19 RNA is a negative
trans-regulator of Igf2 mRNA levels [33] while, in the human, the
91H RNA augments paternal IGF2 expression levels [34].
Furthermore, a study by Wilkin et al. suggested that the activity
linked to the 91H RNA may be restricted to the antisense strand of
the H19 transcription unit [37]. To elucidate the function of the
sense/antisense H19 transcripts, we generated a mouse myoblast
cell line from homozygous H19
D3 KO mice [36] (H19 KO
myoblasts 2/2). These cells express an endogenous 91H RNA
which is truncated within the H19 transcription unit. Therefore,
we suspected that this truncated 91H RNA would not be
functional and that Igf2 expression may be affected in this cell
line. Remarkably, we showed that, as for the classical C2C12
myoblast line, H19 KO myoblasts can differentiate into myotubes
upon 3 days of serum starvation (Figure S1). Using the mE and mF
PCR amplicons (Figure 1), we then showed that the endogenous
truncated 91H RNA displays a similar level of expression
compared to the native 91H RNA in C2C12 myoblasts (Figure
S2A). As found for tissues [34], the endogenous truncated 91H
RNA levels are very low as compared to that of the sense H19
transcript (about 10
3/10
4 lower than H19 RNA levels observed in
C2C12 myoblasts). Interestingly, in early passages of cell culture,
H19 KO myoblasts displayed substantial Igf2 expression levels, as
observed in the muscle of H19
D3 animals [36] (data not shown).
However, in later passages, we found that Igf2 expression levels
were very weak in undifferentiated cells and could only be detected
by RT-qPCR (Figure S2B) but neither inrun-on (Fig. 3A) nor in
Northern-Blot (Fig. 3B) experiments.
Run-on and Northern-blot experiments were also performed on
myoblasts derived from mice having a paternal inheritance of the
H19
D3 deletion (control paternal heterozygous myoblasts: +/2).
These cells display the same genetic background than H19KO
myoblasts and they were cultivated under identical experimental
conditions (late passages of cell culture). However, they harbour
accurate Igf2 transcription (Figure 3A) and regular steady state Igf2
mRNA levels (Figure 3B). Finally, Igf2 dowregulation in H19KO
myoblasts was correlated with a progressive loss of DNA
methylation of the H19 ICR (CTCF site 2) observed upon
Trans-Activation of Igf2 Transcription by 91H RNA
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Igf2 expression in this cell line appears to be linked to ICR
demethylation that may itself result, directly or indirectly, from the
deletion of the H19 transcription unit.
Isolation of H19 KO Myoblast Clones that Express Ectopic
91H and H19 Transcripts
To investigate the possibility that the effect of the H19
transcription unit on Igf2 expression (Figure 3) may depend on
antisense sequences complementary to the H19 gene [34,37], we
then transfected the H19 KO myoblasts with constructs containing
this region with the H19 gene under the control of a strong
promoter (CMV promoter). Unfortunately, despite intensive
efforts, such mini-constructs were systematically unable to express
significant levels of the transgenes in H19 KO myoblast cells.
However, transfection of a 16 kb BamHI-BamHI restriction
fragment encompassing the H19 endodermic enhancers and the
whole H19 gene (Figure 1), displayed some ectopic expression
(Figure 4). This fragment includes the native H19 and the 91H
endodermic promoters and starts at a BamHI restriction site
located 1.8 kb upstream of the H19 start site, thus excluding the
Imprinting Control Region (ICR) of the locus (Figure 1). This
fragment was co-transfected with a hygromicin-resistance plasmid
into H19 KO myoblast cells. Interestingly, after hygromicin
selection, in addition to ectopic 91H/H19 RNAs, we recovered
Igf2 expression in the whole population of transfected cells
(Figure 4A).
We then isolated 16 clones among which 15 displayed
expression from the H19 construct and chose 6 clones for
further characterisation (Figure 4B). All transfected clones
displayed high ectopic H19 and 91H transcript levels
(Figure 4B, left panel). For comparison, in wild-type C2C12
myoblast cells, 91H RNA levels were dramatically lower than
H19 RNA levels (Figure 4B, right panel). Clearly, ectopic 91H
RNA is overexpressed in all transfected cells analysed. However,
contrary to the situation in the wild-type C2C12 cells
(Figures 4B, right panel), neither the ectopic 91H nor the
ectopic H19 transcripts are up-regulated during myoblast
differentiation (Figure 4B, left panel) suggesting that some
regulatory elements are probably missing in the construct used
for ectopic expression. 59RACE experiment performed on total
RNA from one of the clone (clone 4) mapped the same TSS
found in liver for the endogenous 91H RNA (see Figure 2) as
well as two minor upstream start sites (Figure S3). Finally, using
actinomycin D treatments, we definitively validated our
experimental system of cellular complementation by showing
that, mimicking their endogenous counterparts (Figure S4 and
ref. [34,38]), the ectopic H19 RNA is very stable, while the
ectopic 91H transcript is much more labile (Figure S4B).
Ectopic Expressions of 91H and H19 RNAs are Oppositely
Linked to Induced Igf2 Transcription
To investigate gene expression at the transcriptional level, we
performed nuclear run-on experiments on undifferentiated and
differentiated transfected H19 KO myoblasts corresponding to the
whole cell population or to the isolated clones (Figure 5A). Using a
PhosphorImager, we then quantified the relative Igf2 transcription
levels from the autoradiographies shown in Figure 5A. These
experiments showed that Igf2 transcription is undetectable in
untransfected H19 KO myoblasts, while all transfected clones re-
expressed Igf2 at significant levels (Figure 5B). No correlation was
found between Igf2 transcription levels and the 91H/H19
Figure 1. Map of the mouse H19/91H region showing the PCR amplicons used in RT-qPCR experiments. The region corresponding to the
sequence removed by the H19
D3 deletion in the H19 KO myoblasts (see below) is indicated in blue. The H19/91H insert transfected into the H19 KO
myoblast cells is also shown in the figure (green lane). The insert is a 16 kb BamHI-BamHI fragment encompassing the H19 endodermic enhancers
and the whole H19 gene. PCR amplicons used to quantify the ectopic RNAs are indicated (H19 RNA, mI1-mI3, mJ and mC’). DNA methylation is
indicated by black lollipops and RNAs are depicted in red. Positions of restriction sites and PCR amplicons used for real-time PCRs are indicated
relative to the H19 transcription start site. The mA and mB PCR amplicons have been used in a previous study [34] and are indicated here solely for
clarity of our PCR nomenclature. For primer sequences see Table S1.
doi:10.1371/journal.pone.0037923.g001
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2=0.0317, data not shown). This
demonstrates that Igf2 trans-activation occurs at the transcriptional
level and suggests that this trans-activation depends on ectopic
RNA expression.
In agreement with our previous findings in the human
[33,34], Igf2 trans-activation is strongly correlated to the ectopic
91H RNA (R
2=0.6918 ) (Figure 6A). We also observed a
positive correlation between Igf2 transcription and ectopic H19
RNA (R
2=0.5315) levels (Figure 6B). Both RNAs are produced
from the same ectopic copies and therefore, it is not surprising
that both display a positive correlation with Igf2 transcription
levels. This indicates that at least one is truly correlated with
Igf2 transcription. p values indicate that the correlation with
91H RNA is more significant (p=6.10
25) than that with H19
RNA (p=10
23). This result suggests that it is essentially the
ectopic 91H RNA up-regulates Igf2 transcription in trans.
Moreover, very large amounts of ectopic H19 RNA, as
observed in clones 4, 11 and 12ND (see Figure 4B), can
counteract this effect. Indeed, by plotting Igf2 transcription
levels versus the ratio of 91H/H19 ectopic RNA levels, we
observed a clear negative effect of ectopic H19 RNA on Igf2
transcription in these clones where the 91H/H19 ratio was
inferior to 0.2 (Figure 6C, black diamonds). Finally, in all other
clones, where H19 RNA is much lower (in which the 91H/H19
ratio was superior to 0.2), the levels of the H19 RNA do not
display any significant effect on Igf2 transcription levels
(Figure 6C, white diamonds).
We thus propose that the relative sense/antisense ectopic H19
RNA levels are able to control Igf2 trans-activation in our
complementation assay.
Figure 2. Characterisation of TSS of the endogenous mouse 91H RNA. 59RACE experiment was performed on unpolyadenylated and capped
RNA from 7 days-old mouse liver. (A) The RT Primer was designed in the mFb region (Figure 1) and a band was successfully amplified by nested PCRs.
The RT primer corresponds with the forward primer of PCRa and nested PCR reactions were performed using the GeneRacer DNA oligonucleotide as
reverse primer. (B) Ethidium bromide staining of an agarose gel showing PCRs product obtained from amplifications indicated above (MW: Molecular
Weight). Sequencing of PCRa and PCRc products showed that these bands correspond essentially to unspecific amplifications while PCRb correspond
to the TSS of the 91H RNA. (C) Electrophoregram of the sequenced 59RACE product amplified from the capped RNA fraction (PCRb). This sequence
identified a unique Cap site located in the endodermic enhancer 2 at position chr7:149,755,206 or chr7:149,755,207 on mouse July 2007/ mm9
Assembly. Due to the presence of a C residue at the end of the GeneRacer RNA oligonucleotide primer and/or the possibility that the last C residue
may derive from the cap of the RNA, the exact position of the TSS remains ambiguous between two consecutive C residues found in the mouse
genome sequence. (D) The sequence of the endodermic enhancer 2 is indicated in bold. The position of the TSS of the 91H RNA is indicated (black
arrow).
doi:10.1371/journal.pone.0037923.g002
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Without H19 ICR Re-methylation
We then assessed whether Igf2 up-regulation in transfected
H19 KO myoblasts is accompanied by re-methylation of the
H19 ICR. In addidtion, we also investigated the methylation
levels of the other Differentially Methylated Regions (DMRs) of
the locus. In order to determine DMR methylation levels at the
Igf2/H19 locus, we used digestions by methylation-sensitive
restriction enzymes of DNA from untransfected and transfected
H19 KO myoblasts as well as control myoblasts (paternal
heterozygous) (Figure S6). These experiments confirm that
untransfected H19 KO myoblasts are poorly methylated on
Figure 3. Transcriptional and steady state Igf2 RNA levels in control and H19 KO myoblasts. H19 KO myoblats (2/2) have been compared
to cells with a paternally inherited deletion of the H19 transcription unit (control paternal heterozygous myoblats, +/2). These two cell lines have
identical genetic background and were both harvested after identical late passage numbers (passage 40). (A) Run-on analysis of Igf2 and of the 91H/
H19 transcripts. Igf2 transcriptional activity is detected only in control myoblasts (+/2). (B) Northern-blot analyses of Igf2 mRNA and H19 transcript
levels showing two lanes corresponding to two separate samples for each cell type. The same membrane was sequentially hybridized with Igf2, H19
and 18S rRNA probes. The left panel shows an ethydium bromide staining of the agarose-formaldehyde gel before transfer. Note that the Igf2
transcripts are detected only in control cells (+/2). (C) Methylation levels were determined at a BceAI methylation sensitive restriction site located
within the CTCF recognition site 2 of the H19 ICR in H19 KO myoblasts at the indicated passage numbers.
doi:10.1371/journal.pone.0037923.g003
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becomes unmethylated (Figure S6B) while Igf2 DMR2 remains
highly methylated (Figure S6C). Low methylation levels are also
found at the H19 promoter (Figure S7A). However, the IgDMR
at the Dlk1/Gtl2 locus on chromosome 12 remains methylated
(Figure S7B) indicating that the unmethylation observed at the
H19 ICR is not a general phenomenon, since it is not found at
another imprinted locus. In transfected clones, the ICR (Figure
S6A) and Igf2 DMR1 (Figure S6B) show low DNA methylation
levels while Igf2 DMR2 remains largely methylated (Figure
S6C). We conclude that ectopic 91H and H19 RNA expressions
do not convincingly change DNA methylation patterns observed
in untranfected H19 KO myoblasts.
Finally, bisulfite-sequencing experiments confirmed that H19 KO
myoblasts are indeed very poorly methylated on the H19 ICR
(Figure S6E) and that the transfected H19 KO myoblasts that
displaysthehighestIgf2 expressionlevel(clone4)isnotre-methylated
at the H19 ICR (Figure S6F). Oppositely, the H19 ICR is highly
methylated incontrol myoblasts (+/2 and C2C12 cells) (Figure S6D
and S6G). These results clearly indicate that Igf2 trans-activation by
ectopic 91H RNA occurs without H19 ICR re-methylation.
Igf2 Trans-activation by Ectopic 91H RNA Occurs Through
Up-regulation of a Novel Igf2 Promoter
Since Igf2 trans-activation by ectopic 91H RNA can occur
without H19 ICR re-methylation, we decided to investigate in
Figure 4. Quantifications of 91H and H19 ectopic RNAs and endogenous Igf2 RNA levels in transfected H19 KO myoblast cell lines. (A)
The 91H/H19 insert (see Figure 1) have been co-transfected with a hygromicin-resistance plasmid into H19 KO myoblast cells. Ectopic 91H, H19 and
endogenous Igf2 mRNA (Igf2mRNA PCR amplicon) levels were determined by RT-qPCR in undifferentiated H19 KO myoblasts untransfected or
transfected (whole hygromycin-resistant transfected cell population) with the 91H/H19 insert. Results were normalized to Gapdh expression levels. (B)
Comparison between the H19 and 91H ectopic RNA levels. RT-qPCR quantifications were performed in undifferentiated (ND) or differentiated (D). The
whole hygromycin-resistant transfected cells (‘‘whole’’) and 6 isolated clones (left panel), as well as C2C12 myoblasts (right panel), were analysed. The
ectopic H19 RNA expression levels (open bars) were assessed by using qPCR primers located at H19 exon-exon junctions (H19 RNA PCR amplicon).
The ectopic 91H RNA levels (black bars) were quantified with the mC’ and mI1-mI3 PCR amplicons. Error bars correspond to s.e.m. of quantifications
obtained with mC’ and the mean of mI PCR amplicons. Detailed data are shown in figure S5 (see also Materials & Methods section and Table S1).
Please note that the other PCR amplicons shown in Figure 1 also target the endogenous truncated 91H RNA produced from the endogenous locus
and therefore they could not be used to quantify ectopic transcripts. Sample names and transgene copy numbers are indicated below the histogram.
doi:10.1371/journal.pone.0037923.g004
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PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e37923Figure 5. Nuclear Run-on experiments. (A) Autoradiographies of nuclear Run-on experiments on transfected and untransfected H19 KO
myoblasts. Nuclear Run-on experiments were performed as previously described [38] and the a
32P UTP labelled transcripts were hybridized on filters
to denatured plasmids containing the insert DNA of genes indicated on the figure. 91H/H19 transcription was assayed using an insert corresponding
to the H19 sequence and Igf2 with a genomic 2.4 kb BamHI-BamHI DNA fragment encompassing the exon 4-exon 6 region. Such nuclear run-on
experiments were performed on undifferentiated (ND) and differentiated (D) cells either on the whole hygromycin-resistant transfected H19 KO
myoblast cell population (‘‘Whole’’) and transfected clones. (B) The same filters as those used for the autoradiographies shown in A were used for
PhosphorImager quantifications. The ectopic 91H/H19 transcription levels (open bars) were compared to the endogenous Igf2 transcription levels
(black bars). For each hybridized filter, the relative transcription levels were determined for each gene by normalizing to the Gapdh transcription level.
doi:10.1371/journal.pone.0037923.g005
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e37923Figure 6. Comparison between the endogenous Igf2 transcription levels and the steady state levels of the ectopic RNAs. In these
graphs, we compared, for each transfected H19 KO clones, Igf2 transcription data shown in Figure 5B with the steady state 91H and H19 ectopic RNA
levels shown in Figure 4B. (A) Igf2 transcription versus 91H RNA levels. (B) Igf2 transcription versus H19 RNA levels. In untransfected H19 KO myoblasts
(2/2), both 91H and H19 are not expressed (RNA levels =0) and Igf2 transcription level is below the ‘‘empty plasmid’’ background (see Fig. 5A) which
is inferior to 0.11. (C) Igf2 transcription level versus the ratio of 91H/H19 RNA levels. Clones expressing large amount of ectopic H19 RNA (clones 4, 11
and 12ND, black diamonds) (Figure 4B) were analysed separately from the others (ratio of 91H/H19 RNA levels .0.2; open diamonds). In clones
expressing high H19 RNA levels (black diamonds), the ectopic H19 RNA level relative to the 91H RNA level (which leads to a decrease of the 91H/H19
RNA ratio) is inversely proportional to Igf2 transcription levels (R
2=0.8173).
doi:10.1371/journal.pone.0037923.g006
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clones. Surprisingly, promoter usage analyses showed that the
strongest P2/P3 Igf2 promoters were not up-regulated in
transfected H19 KO myoblasts (Figure 7A, left panel). Since, the
P0 and P1 promoters were not significantly expressed (data not
shown), we hypothesized that Igf2 up-regulation may occur by
activation of an unknown Igf2 promoter. To assess this possibility,
we performed 59 RACE experiments in clone 4 that displays the
highest Igf2 transcriptional activity (see Figure 5B). We identified a
novel capped Igf2 mRNA which contains a new exon which is
141nt long and is spliced to the exon 4 common to all known Igf2
mRNAs (Figure 7B/C). This new transcript is initiated from a
novel TSS located in the DMR1 (position chr7: 149,852,285 on
mouse July 2007 mm9 Assembly). Using primers specific of the
new Igf2 exon, we determined the levels of this novel Igf2 mRNA
in different mouse tissues and showed that, while being poorly
abundant, it is more expressed in mesodermic tissues (kidney,
tongue and heart) than in liver or brain. We therefore called it
‘‘mesodermic’’ promoter (Pm) (Figure 8A).
We then analysed the Pm transcript in all our myoblastic cell
lines. It turns out that this mRNA, like the other Igf2 transcripts,
was down-regulated in the H19 KO myoblasts compared to
control myoblasts (+/2) (Figure 8B). Remarkably, opposite to all
the other Igf2 transcripts, it was trans-activated in all transfected
H19 KO myoblasts except clone 11 which displays the lowest
DMR2 methylation levels in addition to ICR hypomethylation
(see Figure S6C and S6A respectively). Globally, the mean Pm Igf2
mRNA level showed 10 fold up-regulation in transfected clones
compared to untransfected H19 KO myoblasts and reached P3
Igf2 mRNA levels (Figure 7A, right panel). Therefore, we conclude
that Igf2 trans-activation by ectopic 91H RNA occurs essentially
through up-regulation of the Pm Igf2 promoter.
Discussion
We recently contributed to show that, in the human, a large
antisense H19 transcript (91H RNA) regulates Igf2 mRNA levels
[34] whereas, in the mouse, the H19 RNA is a negative trans-
regulator of Igf2 mRNA levels [33]. In the present work, we
derived an H19 KO myoblast cell line from mice carrying a
deletion of the H19 transcription unit (H19
D3) [36] in which the
Igf2 gene is repressed. Remarkably, loss of Igf2 transcription in
H19 KO myoblasts correlates with a loss of H19 ICR methylation.
It is therefore very likely that the CTCF protein binds to the ICR
on both parental alleles leading to an almost complete insulation of
the regular P2/P3 Igf2 promoters from the enhancers. Using a
genetic complementation approach (reintroduction of the H19
sequence in H19 KO myoblasts), we investigated steady-state
levels and halves-lives of ectopic 91H and H19 RNAs, as well as
endogenous Igf2 transcriptional activity, and we show (i) that
strong ectopic expression of antisense H19 transcripts synthesized
from the enhancer 2 region can release Igf2 silencing in mouse
myoblasts (ii) that this Igf2 reactivation takes place at the
transcriptional level by targeting a previously unknown Igf2
promoter and (iii) that a large amount of ectopic H19 RNA can
counteract Igf2 trans-activation by ectopic 91H RNA. Strikingly,
we show that trans-activation of this novel Pm Igf2 promoter occurs
without H19 ICR re-methylation indicating that this promoter is
able to by-pass the insulator function of the unmethylated ICR. It
thus remains possible that Pm activity also occurs on the maternal
allele. This effect may potentially rely on the activity of the DMR2
that remains largely methylated in our experimental system
(Figure S6C) and is known in mouse to favour Igf2 transcription on
the methylated paternal allele [39]. This possibility would be
reminiscent to some human pancreatic tumors like insulinomas
where Igf2 DMR2 is hypermethylated while the H19 ICR is
monoallelically methylated and where Igf2 becomes also expressed
from the unmethylated maternal allele (loss of imprinting) [40].
Altogether, our inactivation/complementation approach, in
conjunction with other recent findings [33,34], reveals that the
mouse H19 antisense RNA favours Igf2 transcription and activates
the Igf2 Pm promoter while large amounts of the H19 transcript
counteract this effect, suggesting that these two transcripts are
antagonist trans riboregulators (Figure 9). Therefore, in cells like
the C2C12 myoblasts where we observe very low amounts of 91H
RNA and large amounts of H19 RNA, one can expect that the
endogenous H19 RNA exerts a strong Igf2 transcriptional
repression at least on the Pm promoter.
Our experiments also agrees with the pioneer work by Wilkin et
al. which suggested that, in human, a partial H19 cDNA construct
could activate IGF2 when expressed in the antisense orientation
while H19 RNA can repress transcription from the IGF2 P3
promoter [37]. However, at that time, the endogenous antisense
H19 RNA was unknown and its effect in this work remained
enigmatic.
Our results reveal a functional relationship between H19 and
91H RNAs. Consequently, depending on the cell context, the
functional relevance of the H19 transcriptional unit for Igf2 gene
control will depend on the relative expression levels of the sense
and antisense H19 transcripts. This finding is particularly relevant
for a better understanding of the conflicting data obtained for H19
gene expression in cancer cells and tumours. Indeed, 91H RNA
levels should be taken into consideration as this transcript is a good
marker of tumourigenesis in breast cancer cells [34]. In summary,
the 91H RNA could be assumed to be oncogenic by favouring Igf2
transcription while H19, which counteracts this effect, would act as
a tumour suppressor [23]. Consistently, normal breast tissues
display high H19 and very low 91H RNA levels, while the opposite
is observed in cancerous breast tissues [34]. Interestingly, the effect
of the 91H RNA on Igf2 derepression observed here in
complementation studies, may explain the Igf2 derepression
occurring in many tumours where 91H RNA was found to
accumulate while the H19 gene is maintained in a repressed state
[34]. One can note that an H19 antisense transcript called H19
opposite tumor suppressor (HOTS) was recently found in human
[41]. It extends from 2.8 kb downstream of H19 to 1 kb upstream
and is encoding a nucleolar protein which is not conserved in the
mouse. An evolutionarily conserved microRNA miR675 has been
also described in the H19 exon 1 [42,43]. Recently, this H19-
derived miR-675 was shown to regulate tumor suppressor RB in
human colorectal cancer favoring its progression [44]. An
interesting possibility is that this miRNA may also be directly
involved in controlling levels of 91H RNA. An open question is
why, in vivo, so much H19 RNA would be required to produce this
miRNA and to control such small amounts of 91H RNA? This
may be due to the fact that the H19 RNA is mainly cytoplasmic
while the 91H transcript is nuclear [34]. Therefore, only a small
sub-set of nuclear H19 RNA may be involved in this process.
Furthermore, the miRNA production does not appear to
significantly affect H19 RNA levels and therefore this process
should not interfere with other functions that the H19 RNA may
have in the cytoplasm where it is known to localize with the
polysomes [38,45]. Alternatively, the opposite effects of the 91H
and H19 RNAs on Igf2 transcription may occur through more
indirect mechanisms involving for example the Igf2 DMRs.
Here, upon isolation of H19 KO mouse myoblasts, the Igf2
gene expression was strongly decreased after passages in cell
culture probably due to the observed loss of H19 ICR DNA
Trans-Activation of Igf2 Transcription by 91H RNA
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changed as a consequence of cell culture. Alternatively, this may
also result from the deletion of the H19 transcriptional unit. In
the mouse mesoderm-derived tissues, and more particularly in
the postnatal muscle, maternal inheritance of the H19
D3
deletion is known to lead to loss of Igf2 imprinting and re-
expression of this gene from the maternal allele [23,36]. In the
physiological context of this tissue, the presence of other cell
types, such as for example satellite cells, may strongly contribute
to maintain normal Igf2 levels by signalling through intercellular
pathways which may control myoblast cell differentiation [46].
In the present study, we reactivated Igf2 transcription in H19
KO myoblasts by ectopic 91H RNA expression without H19
ICR re-methylation. Although we could not investigate whether
this reactivation is monoallelic or biallelic, both parental alleles
are largely unmethylated since methylation levels are very low
(Figure S6) indicating that Igf2 reactivation could occur on both
parental alleles.
It now would be of interest to modify in the animal the 91H
RNA levels independently of H19 RNA levels, as performed above
Figure 7. Characterization of a novel Igf2 Pm transcript. (A) Comparison of Igf2 transcripts produced from the P2/P3 (left panel) or Pm (right
panel) promoters in untransfected (2/2) and transfected (‘‘clones’’) H19 KO myoblasts. Transcript levels are given relative to the P3 transcript level in
untransfected H19 KO myoblasts (2/2) (100%). (B) Characterization of the TSS of the endogenous Igf2 Pm transcript. 59RACE experiment was
performed on total capped RNA from transfected H19 KO myoblasts (clone 4). The primer used for RT is the E4_AS3 and PCR reactions were
performed using the Gene Racer primer and the E4_AS2 and then the E4_AS1 primers for nested PCR. The ethidium bromide staining of an agarose
gel shows PCR products obtained from nested PCR amplifications. Sequencing of PCR product (Pm band) showed that it corresponds to a novel TSS
of the Igf2 gene (position chr7: 149,852,285 on mouse July 2007/ mm9 Assembly). The smaller band in the gel corresponds to the Igf2 P3 transcript
(data not shown). On the left is shown a 100bp-molecular weight ladder (C) The sequence of the novel Igf2 Pm exon is given in blue and the novel
splice site with exon 4 (purple) is indicated below. Intronic sequences are indicated in red. SD= Splice Donor; SA=Splice Acceptor; The indicated CT
dinucleotide corresponds to the splice acceptor site of an intron of a Igf2 antisense RNA [58]. (D) Map of the Igf2 gene showing the Igf2 Pm promoter
(blue rectangle). The sense and antisense Igf2 exons are shown as black and white rectangles respectively. The first intron of the Pm Igf2 mRNA is
indicated in red.
doi:10.1371/journal.pone.0037923.g007
Figure 8. Igf2 Pm mRNA levels in mouse tissues and Igf2 promoter usage in transfected H19KO myoblasts. (A) Pm Igf2 mRNA levels
relative to total Igf2 mRNA level (100%) in different mouse tissues. Total Igf2 mRNA levels were determined by RT-qPCR using a PCR primer pair
(Igf2exon6 PCR amplicon) located in the exon 6 common to all Igf2 transcripts. (B) Igf2 promoter usage in untransfected/transfected H19 KO
myoblasts. Relative mRNA levels (%) are calculated relative to the P3 Igf2 transcript level in the control cells (+/2) (100%).
doi:10.1371/journal.pone.0037923.g008
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experiment is tricky to do in vivo since both RNAs possess identical
expression patterns and are both produced from the maternal
allele. Furthermore, the investigations should be performed at the
transcriptional level (nuclear run-on assays) to exclude any
potential post-transcriptional effects. Finally, a transgenic line that
would display high ectopic 91H RNA but low ectopic H19 RNA
has not yet been produced. Such a transgenic mouse strain would
be important to confirm the results obtained here in myoblast cell
lines. However, 91H RNA expression should be altered in the
minute mouse mutant. Indeed, Davis et al. [47] have shown that the
minute (Mnt) mutation is an inversion that disrupts a candidate
region for muscle specific enhancers and, in mesodermic tissues,
91H RNA is initiated downstream of the endodermic enhancers,
most probably in the sequence inverted in minute mice. However,
we cannot rule out that the H19 antisense RNA expression may
persist in Mnt mice by activation of some propitious transcription
start sites. Therefore, it may be interesting to investigate 91H and
Igf2 Pm transcript levels in this mouse mutant.
Since we previously demonstrated that the 91H RNA acts in
trans on Igf2 mRNA levels in human cells, one could hypothesize
that this RNA may act exclusively at the post-transcriptional level.
The present work clearly demonstrates that this is not the case,
and that the 91H RNA augments Igf2 expression by acting at the
transcriptional level. This finding raises the question about the
mechanisms involved in such a regulation. Igf2 transcriptional
regulation is known to be controlled through long-range interac-
tions between regulatory elements, such as the Differentially
Methylated Regions (DMRs) and the enhancers located down-
stream of H19 [18,48,49]. We could therefore propose that the
91H RNA can up-regulate tissue-specific Igf2 transcription by
contributing, directly or indirectly, to higher-order chromatin
architecture of this locus. For example, it may favour interactions
between the Igf2 gene and specific enhancers since our experi-
ments show that, in myoblastic cells, the 91H RNA can reactivate
the Pm Igf2 promoter which is used in mesodermic tissues.
Alternatively, the 91H RNA could also titrate factors such as
transcriptional repressors, targeting Igf2 as well as some other
genes of the Imprinted Gene Network (IGN) [32]. Finally, the 91H
RNA is produced in liver from the endodermic enhancers
(Figure 2) that themselves control the H19 expression levels in cis
[50]. It is also able to act in trans to control Igf2 transcription
(Figure 5) and to up-regulate the Pm transcript (Figure 8).
Therefore, this lncRNA appears as a novel important player for
co-regulation of genes at the Igf2/H19 locus.
Materials and Methods
Ethics Statement
All experimental designs and procedures are in agreement with
the guidelines of the animal ethics committee of the French
‘‘Ministe `re de l’Agriculture’’. Our animal unit has been registered
at the departmental office for population protections (Direction
de ´partementale de la protection des populations) at the ‘‘He ´rault
pre ´fecture’’ (Agreement NuE34-172-16). All the experimental
protocols (mouse dissections) have been specifically approved by
the inspector in charge of the veterinary public heath from the
same office at the ‘‘He ´rault pre ´fecture’’ (Agreement Nu34-31).
Isolation of H19 KO Myoblasts
Primary cultures were prepared from the thigh muscles of
H19
D3 mice as previously described [51]. Primary cells (H19 KO
and control paternal heterozygous myoblasts) were serially
passaged for analysis. Using qPCR on genomic DNA we checked
that, as expected, the isolated H19 KO myoblasts were devoid of
the H19 transcription unit and that the Igf2 gene was in an
identical copy number in H19 KO myoblasts as in C2C12
myoblast cells, suggesting that no aberrant loss or duplication of
chromosome 7 occurred in the H19 KO myoblast cell line (data
not shown).
Cell Culture and Transfections
H19 KO (2/2) and control paternal heterozygous (+/2)
myoblasts were cultured in DMEM/MCDB 1:1, containing 20%
FCS and 2% Ultroser (Gibco). Cells were differentiated into
myotubes upon 3 days of serum starvation. The 16 kb BamHI-
BamHI fragment corresponding to the H19 gene locus (Figure 1)
was cloned into the Not I site of the pBluescript plasmid using
appropriate linkers. The construct was digested with Not I and the
insert was gel-purified before being co-transfected with a
hygromicin-resistance plasmid into H19 KO myoblast cells using
lipofectamin (Gibco) according to the recommendations of the
manufacturer. Actinomycin D at a final concentration of 5 mg/ml
was added to the cell culture medium for the times indicated in
figure legends.
RNA Isolation, Northern-blot and RT-qPCR Analyses
Total RNA was isolated from mouse tissue samples or from
myoblastic cells by the guanidinium thiocyanate procedure as
previously described [38]. Non-polyadenylated RNAs were
prepared by using the PolyA Tract mRNA isolation system IIIH
(Promega). The Igf2 and H19 RNAs were analysed in Northern-
blots as previously described [52]. Reverse transcriptions and real-
time quantitative PCRs were performed as previously described
[34,53] using a qPCR mix described in Lutftalla et al. [54] with
some modifications given in Court et al. [55]. The Igf2 steady-state
mRNA levels were quantified using a PCR amplicon which
targeted the messenger RNA (for primer sequences see Table S1).
The ectopic H19 RNA levels were quantified using primers
Figure 9. Model of regulation of Igf2 transcription by 91H and
H19 RNAs in myoblastic cells. This model is based on the three
critical parameters that we have quantified in this work: the Igf2
transcription levels, the 91H and H19 steady state RNA levels. 91H and
H19 RNAs are direct and/or indirect antagonists riboregulators of Igf2
transcription. H19 appears as having a negative effect on Igf2
transcription while 91H RNA has an opposite effect. Interestingly, 91H
RNA stimulates a new Igf2 promoter (Pm) located within the Igf2
Differentially Methylated Region 1 (DMR1).
doi:10.1371/journal.pone.0037923.g009
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transcript was quantified either in the intergenic region between
the endodermic enhancers and the H19 gene (mC’, mD, mE, mF
and mJ PCR amplicons) or within the H19 introns (mI1, mI2 and
mI3 PCR amplicons) (Figure 1 and Table S1). Indeed, since the
levels and the halve-lives of the RNAs quantified by the intronic
PCR amplicons are similar to those quantified by the mC’ PCR
amplicon, we assume that the H19 intron sequences essentially
account for the ectopic 91H RNA in transfected H19 KO
myoblasts (Figure S5). Throughout this work RNA levels
determined by RT-qPCR were expressed relative to Gapdh mRNA
levels. Igf2 promoter usage was assessed by quantifying transcripts
on each promoter-specific exon (first exons).
59RACE
Rapid Amplification of 59 complementary DNA Ends
(59RACE) was performed on non-polyadenylated d7 mouse liver
RNAs (endogenous 91H RNA) or transfected H19 KO myoblast
RNAs (clone 4) (ectopic 91H RNA and endogenous Igf2 Pm
transcript) according to manufacturer’s instructions (GeneRacerH
Kit from Invitrogen ref. L1502). RT and nested PCR Primer
sequences are given in Table S1.
Transgene Copy-number Determination
Transgene copy-numbers were determined by qPCR relative to
the endogenous Igf2 gene.
Nuclear Run-on
Isolation of nuclei and nuclear run-on experiments were
performed as previously described [38,53].
DNA Methylation Analyses
Each sample was digested by the StyI restriction enzyme (20
units) to eliminate potential PCR bias due to the reduced
accessibility of primers on undigested genomic DNA [56]. For
H19 ICR methylation analyses (CTCF site 2), half of each samples
was then additionally digested by the BceAI methylation-sensitive
enzyme (4 Units/reaction) and qPCR quantifications were
performed on BceAI-digested and undigested fractions after
normalization against a loading control (242C19 primer pair). A
similar approach was followed using the methylation-dependent
McrBC enzyme to determine methylation levels in the Ig-DMR
(Dlk1/Gtl2 locus on mouse chromosome 12) [57] or methylation-
sensitive enzymes (NaeI for Igf2 DMR1 and HpaII for Igf2
DMR2). Methylation levels of the CpG residues studied for the
H19 ICR and Igf2 DMRs are known to be representative of DNA
methylation levels of the whole DMRs [52]. Primer sequences are
available in Table S1.
Bisulfite Treatments
Genomic DNA was prepared from myoblastic cells and
conversion with sodium bisulfite was performed with the EpitectH
kit (Qiagen) following the manufacturer’s instructions. PCR
fragments were cloned using a PCR cloning Kit from Qiagen.
Clones with strictly identical patterns of conversion were removed
from the results (since they are likely to represent identical
molecules). We used the MethPrimer software to design primers
on bisulfite treated DNA. Primer sequences are available in Table
S1.
Supporting Information
Figure S1 Differentiation of H19 KO myoblast cells. The figure
shows pictures of the H19 KO myoblasts under the optical
microscope (206 enhancement) during the myogenic differentia-
tion process (ND= undifferentiated; d1, d2 and d3 correspond to
1, 2 or 3 days of differentiation). The transcriptional levels of the
myogenin, a myogenic marker, are up-regulated during differenti-
ation of H19 KO myoblast cells with the same amplitude (6–7 fold)
as observed in C2C12 myoblasts (data not shown).
(TIF)
Figure S2 Quantifications of the intact or truncated endogenous
91H RNA levels (A) and of Igf2 mRNA (B) relative to gapdh mRNA
levels in myoblast cell lines. (A) Comparison between the intact
(black bars) and truncated (grey bars) endogenous 91H RNA levels
determined by RT-qPCR in C2C12 myoblasts and H19 KO
myoblasts respectively. (B) Quantification of Igf2 mRNA levels
during differentiation of H19 KO myoblasts (late passage cells)
(ND= undifferentiated; D= differentiated). One can note that, as
observed for the endogenous truncated 91H RNA (Figure S2A),
the low Igf2 levels observed in H19 KO myoblasts were strongly
up-regulated (by at least 20-fold) during myogenic differentiation
(Figure S2B). This suggests that the H19 transcription unit is
dispensable to Igf2 up-regulation processes observed during
myogenic differentiation.
(TIF)
Figure S3 Characterisation of TSS of the ectopic mouse 91H
RNAs. 59RACE experiments were performed on total capped
RNA from transfected H19 KO myoblasts (clone 4). (A) Map of
the enhancer region showing the primers used for RT and PCR
reactions. The RT was initiated from the forward primer of PCRa.
(B) Ethidium bromide staining of an agarose gel showing PCRs
product obtained from amplifications as indicated in Figure 2B)
(MW: Molecular Weight). Sequencing of PCRa product showed
that this band corresponds essentially to unspecific amplification
while PCRb correspond to the major TSS of the 91H RNA
(position chr7:149,755,206 or chr7:149,755,207 on mouse July
2007/ mm9 Assembly) and PCRc contains two minor TSS
initiated within the endodermic enhancer 2 sequence upstream
of the major TSS. These minor TSS could be identified in this
experiment probably because ectopic 91H RNA is overexpressed
compared to its endogenous counterpart. (C) The sequence of the
endodermic enhancer 2 is indicated in bold. The positions of the
minor and major TSS are indicated by black arrows. Due to the
presence identical nucleotidic sequences at the end of the
GeneRacer RNA oligonucleotide primer and at the TSS, the
exact position of the major and one minor TSS remain
ambiguous.
(TIF)
Figure S4 Endogenous vs ectopic 91H/H19 RNA half-lives. (A)
Stability of the endogenous 91H and H19 RNAs in C2C12
myoblasts. C2C12 myoblast cells were treated with Actinomycin
D and relative RNA levels were determined by real time RT-
qPCR at the indicated times (in hours). Data were normalized to
Gapdh expression levels. H19 (H19 RNA PCR amplicon), 91H
(RT-qPCR quantifications with the mC’ PCR amplicon) and H19
precursor (intron 2, mI2 PCR amplicon) RNA levels are shown.
Note that the half-life of the 91H RNA (middle panel) is similar to
that of an unspliced H19 precursor RNA (right panel). (B) Stability
of the ectopic 91H and H19 RNAs were determined in transfected
H19 KO myoblasts using the same PCR amplicons as above. The
whole hygromycin-resistant transfected H19 KO myoblast cell
population was treated with Actinomycin D as described above
and the ectopic H19 and ectopic 91H RNA levels were quantified
as indicated above. Note that the ectopic 91H RNA appears to be
more stable than the endogenous 91H transcript in C2C12 cells
(compare Figure S4A with Figure S4B). This may be due to the
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H19 KO myoblasts relative to the endogenous levels observed in
C2C12 cells (Figure 4B, compare right and left panels). Since,
in transfected KO myoblasts, the ectopic 91H RNA is found in
similar amounts as the ectopic H19 RNA (Figure 4B, left panel)
despite its low stability (Figure S4B), we should conclude that
ectopic 91H transcription is much higher than that of the ectopic
H19.
(TIF)
Figure S5 RT-qPCR quantifications of 91H RNAs. Note that,
in C2C12 cells, quantifications by the mI1-mI3 PCR amplicons
(blue bars) account for the endogenous H19 precursor RNA level
but not the endogenous 91H transcript which is much lower as
shown using the mC’ PCR amplicon (red bar). In the opposite, in
transfected H19 KO myoblasts, quantifications using the mI1-mI3
PCR amplicons, as well as with the mC’ PCR amplicon, account
for the ectopic 91H RNA level which is very high. The 91H RNA
levels shown in Figure 4B corresponds to the mean of
quantifications using mC’ and mI1-mI3 PCR amplicons.
(TIF)
Figure S6 DNA methylation patterns of H19 ICR and Igf2
DMRs. Methylation patterns were analysed in control (+/2) and
H19 KO (2/2) myoblasts after 40 passages and in transfected
clones, 3 passages after clonal isolation. The methylation pattern
of the H19 ICR (A), the Igf2 DMR1 (B) and Igf2 DMR2 (C) were
estimated by digestion of the genomic DNA with methylation-
sensitive restriction enzymes (BceAI, NaeI and HpaII for ICR,
DMR1 and DMR2 respectively) and quantifications by qPCR.
Noteworthy, this BceAI site encompasses CpG dinucleotides from
CTCF site 2 of the H19 ICR. Error bars represent s.e.m. of
quantifications performed on at least two independent digestions.
Methylation patterns of the H19 ICR around CTCF site 2 was
determined by bisulfite sequencing in control (+/2) (D), H19 KO
(E), clone 4 (F) and C2C12 (G) myoblasts. Black and white circles
indicate methylated and unmethylated CpGs respectively.
(TIF)
Figure S7 Methylation patterns of H19 promoter and IgDMR
(Dlk1/Gtl2 locus on mouse chromosome 12). DNA methylation
patterns were analysed in control (+/2) and H19 KO (2/2)
myoblasts after 40 passages and in the transfected clone 4 (3
passages after clonal isolation) as well as in C2C12 cells. The
methylation pattern of the H19 promoter (A) and the IgDMR (B)
were estimated by digestion of the genomic DNA with
methylation-sensitive/dependent restriction enzymes (HpaII and
McrBC for H19 promoter and IgDMR respectively). Error bars
represent s.e.m. of quantifications performed on at least two
independent digestions.
(TIF)
Table S1 Sequences of the qPCR primers used in the present
work. Primers indicated in bold were also used in RT reactions.
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